Finnegan eBook Summarizes Various AIA Considerations and U.S. Patent Trends in Chemical and Pharmaceutical Industries
December 05, 2013
Authored and Edited by Adriana L. Burgy
On December 2, 2013, Finnegan launched The Chemical and Pharmaceutical Innovation Report 2013. The Report is a complementary eBook for patent practitioners, entrepreneurs, business executives, venture capitalists, and inventors that benchmarks the patent activities in the chemical and pharmaceutical industries from 2006 to 2012.
The Report includes concise summaries of the changes under the America Invents Act (“AIA”). The AIA sections summarized include: best mode, derivation proceedings, first-inventor-to-file, inter partes review, post grant review, pre-issuance submissions, and supplemental examination. These summaries identify considerations for developing and optimizing patent strategies and describe the various proceedings that may be utilized in lieu of or in addition to litigation.
The Report 2013 also details chemical and pharmaceutical patenting and application publication trends, district court litigation trends, appellate litigation trends, and categorizes Federal Circuit decisions from 2006 to 2012.
Download a complimentary copy of The Report 2013 eBook here.
Contacts
Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information.
